$3.70
-0.06-1.6%
Last update: Oct 2, 4:00 PM
$3.70
-0.06-1.6%
Whitehawk Therapeutics Inc
WHWKNASDAQ
Whitehawk Therapeutics (WHWK) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.28 | $-0.33 | $-0.38 | $-0.34 |
| Actual | $-0.20 | $-0.32 | $-0.34 | $-0.26 |
| Surprise | +28.6% | +3.03% | +10.5% | +23.5% |
| Revenue | ||||
| Estimate | — | — | $20.0M | $33.3M |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | -100.0% | -100.0% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.25 | $-0.23 | $-0.26 | $-0.26 |
| Revenue | ||||
| Consensus | $-383330 | $-766670 | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.20 | $-0.28 | 28.6 % |
| Q1 | May 7, 2026 | $-0.32 | $-0.33 | 3.03 % |
| Q4 | Mar 12, 2026 | $-0.34 | $-0.38 | 10.5 % |
| Q3 | Nov 6, 2025 | $-0.26 | $-0.34 | 23.5 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | Mar 12, 2026 | $0 | $20.00M | -100.0 % |
| Q3 | Nov 6, 2025 | $0 | $33.33M | -100.0 % |
| Q2 | Aug 7, 2025 | $0 | $60.00M | -100.0 % |
| Q3 | Nov 6, 2024 | $7.21M | $6.60M | 9.27 % |
